<DOC>
	<DOCNO>NCT01629433</DOCNO>
	<brief_summary>In last year , botulinum toxin type A ( onab/A ) increasingly use treatment option overactive bladder symptom patient affect either neurogenic idiopathic detrusor overactivity ( DO ) . How onab/A inject detrusor muscle improve overactive bladder symptom neurologic patient partially investigated.Some evidence suggest neurotoxin probably reduce detrusor muscle contraction block detrusor muscle cholinergic innervation . However , recent experimental observation indicate onab/A determines complex effect bladder activity act afferent innervation well efferent one . Only experimental study investigate activity onab/A bladder afferent nervous transmission . Experimental study animal show Nerve Growth Factor ( NGF ) elicit increase sensation , urgency DO . Although evidence ability onab/A improve DO reduce bladder urinary content NGF , onab/A influence NGF expression expression TrKa , p75 TRPV1 receptor still unclear . The hypothesis onab/A reduces NGF bladder tissue level time modulate gene expression NGF associate receptor ( TrkA , p75 TRPV1 ) .</brief_summary>
	<brief_title>Onabotulinumtoxina Intradetrusorial Injections NGF Expression</brief_title>
	<detailed_description>NGF suggest modulate neurotransmitter ' release , induces synaptic reorganization influence neuronal excitability act Trk/A p75 associate receptor . Moreover , recent observation indicate NGF-induced DO noxious input depend interaction NGF TRPV1 , over-expressed overactive bladder interstitial cystitis/painful bladder syndrome . From clinical point view , decrease urinary NGF level detect patient DO treat onab/A . Although evidence ability onab/A improve DO reduce bladder urinary content NGF , onab/A influence NGF expression expression TrKa , p75 TRPV1 receptor still unclear .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Reflex , Abnormal</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Patients affect refractory overactive bladder ( OAB ) symptoms detrusor overactivity ( idiopathic neurogenic DO ) refractory conventional anticholinergic ( least 3 antimuscarinic agent tolterodine , oxybutynin solifenacin take least 1 month ) . OAB symptom due bladder outlet obstruction urogenital prolapse female benign prostatic hyperplasia male , recurrent urinary tract infection , cognitive impairment , pregnancy , anticoagulant therapy , psychoactive agent modulate bladder function ( venlafaxine , amitriptyline ) , aminoglycosides , drug think interfere bladder function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>idiopathic detrusor overactivity</keyword>
	<keyword>neurogenic dysfunction</keyword>
	<keyword>onabotulinumtoxinA</keyword>
</DOC>